BackgroundCheck.run
Search For

Paul L May, 879655 S Forest Ave, Chicago, IL 60628

Paul May Phones & Addresses

9655 S Forest Ave, Chicago, IL 60628    773-5500509   

Griffith, IN   

Markham, IL   

Stone Mountain, GA   

Work

Company: Paul may realty group Address: 17220 Browning Dr, Orland Park, IL 60467 Industries: Real Estate Agents and Managers

Mentions for Paul L May

Career records & work history

Lawyers & Attorneys

Paul May Photo 1

Paul May - Lawyer

Office:
Tripp Scott
Specialties:
Construction Law, General Commercial Litigation, Labor and Employment
ISLN:
1000799600
Admitted:
2017
University:
University of Alabama, B.A.
Law School:
Stetson University College of Law, J.D.
Paul May Photo 2

Paul May - Lawyer

Specialties:
Securities, Business, Financial Markets and Services, Public Finance & Tax Exempt Finance, Securities & Investment Fraud
ISLN:
905076230
Admitted:
1991
University:
College of the Holy Cross, B.A., 1975
Law School:
Brooklyn Law School, J.D., 1990

License Records

Paul Michael May

Licenses:
License #: 2705133259 - Expired
Category: Contractor
Issued Date: Feb 23, 2010
Expiration Date: Feb 29, 2012
Type: Class C

Paul D May

Licenses:
License #: 8867 - Active
Category: Water Operator
Issued Date: Nov 17, 2015
Effective Date: Jan 4, 2016
Expiration Date: Dec 31, 2017
Type: Grade VI Water Operator

Publications & IP owners

Us Patents

Peptide Analog Type-B Cck Receptor Ligands

US Patent:
5340802, Aug 23, 1994
Filed:
Jan 29, 1993
Appl. No.:
8/011055
Inventors:
Kazumi Shiosaki - Libertyville IL
Alex M. Nadzan - San Diego CA
David S. Garvey - Lake Forest IL
Youe-Kong Shue - Vernon Hills IL
Mark S. Brodie - Glenview IL
Mark W. Holladay - Libertyville IL
John Y.-L. Chung - Edison NJ
Michael D. Tufano - Chicago IL
Paul D. May - Richland MI
Assignee:
Abbott Laboratories - Abbott Park IL
International Classification:
A61K 3702
C07K 506
C07K 508
C07K 510
US Classification:
514 18
Abstract:
Peptide analog type-B CCK receptor ligands or pharmaceutically-acceptable salts thereof, which are useful for treating central nervous system disorders, substance abuse, gastrointestinal disorders, endocrine disorders, eating-related disorders and for the treatment of shock, respiratory and cardiocirculatory insufficiencies.

Benzoylphenyl Pyridinylthiazolidine Compounds As Platelet Activating Antagonists

US Patent:
5120751, Jun 9, 1992
Filed:
Mar 29, 1991
Appl. No.:
7/677687
Inventors:
James B. Summers - Libertyville IL
Douglas H. Steinman - Morton Grove IL
Denise E. Guinn - Grayslake IL
Steven K. Davidsen - Mundelein IL
Paul D. May - Bristol WI
Assignee:
Abbott Laboratories - Abbott Park IL
International Classification:
C07D41704
A61K 3144
US Classification:
514342
Abstract:
Benzoylphenyl derivatives of 2-(3-pyridinyl)-3-alkyl-4-thiazolidinecarboxamide, 2-(3-pyridinyl)-thiazolid-4-ylacetamide, 2-(3-pyridinyl)-4-dithiolanecarboxamide or 2-(3-pyridinyl)dithiolan-4-yl] urea are potent inhibitors of PAF and are useful in the treatment of PAF-related disorders including anaphylactic shock, respiratory distress syndrome, acute inflammation, delayed cellular immunity, parturtition, fetal lung maturation, and cellular differentiation.

Platelet Activating Antagonists

US Patent:
5120749, Jun 9, 1992
Filed:
Feb 20, 1991
Appl. No.:
7/658134
Inventors:
James B. Summers - Libertyville IL
George S. Sheppard - Wilmette IL
James G. Phillips - Antioch IL
Daisy Pireh - Lincolnshire IL
Douglas H. Steinman - Morton Grove IL
Paul D. May - Bristol WI
Assignee:
Abbott Laboratories - Abbott Park IL
International Classification:
C07D40314
C07D40114
A61K 3140
US Classification:
514337
Abstract:
Indole compounds substituted at the 1- or 3 position by a (pyrid-3 yl)thiazolid-4-yl)alkyl-, (pyrid-3-yl)thiazolid-4-oyl)-, (pyrid-3-yl)dithiolan-4-yl)alkyl- or (pyrid-3-yl) dithiolan-4-ol)- group are potent inhibitors of PAF and are useful in the treatment of PAF-related disorders including anaphylactic shock, respiratory distress syndrome, acute inflammation, delayed cellular immunity, parturtition, fetal lung maturation, and cellular differentiation.

Platelet Activating Factor Antagonists

US Patent:
5382670, Jan 17, 1995
Filed:
Jul 7, 1993
Appl. No.:
8/084257
Inventors:
James B. Summers - Libertyville IL
George S. Sheppard - Wilmette IL
James G. Phillips - Antioch IL
Daisy Pireh - Lincolnshire IL
Douglas H. Steinman - Morton Grove IL
Paul D. May - Richland MI
Denise E. Guinn - Grayslake IL
H. Robin Heyman - Chicago IL
George M. Carrera - Des Plaines IL
Steven K. Davidsen - Mundelein IL
Assignee:
Abbott Laboratories - Abbott Park IL
International Classification:
C07D21304
C07D20904
C07D27704
US Classification:
546273
Abstract:
Indole compounds substituted at the 1- or 3-position by a (pyrid-3-yl)thiazolid-4-yl)alkyl-, (pyrid-3-yl)thiazolid-4-oyl)-, (pyrid-3-yl)dithiolan-4-yl)alkyl- or (pyrid-3-yl)dithiolan-4-oyl)- group are potent inhibitors of PAF and are useful in the treatment of PAF-related disorders including septic shock, respiratory distress syndrome, acute inflammation, delayed cellular immunity, parturtition, fetal lung maturation, and cellular differentiation.

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.